The treatment of choice for ventricular fibrillation is immediate defibrillation, an electrical shock delivered to the heart to reset its chaotic rhythm. Every minute without defibrillation reduces the chance of survival by roughly 10%, and after 10 minutes the odds of successful resuscitation drop to near zero. That narrow window makes speed the single most important factor in treating this condition.
Why Defibrillation Works
During ventricular fibrillation, the heart’s lower chambers quiver rapidly and randomly instead of pumping blood. Electrically, disorganized waves of activity circle through the heart muscle, constantly re-exciting tissue before it has time to recover properly. The heart isn’t technically “stopped” but it can’t generate any useful blood flow, so the effect is the same as if it were.
A defibrillation shock forces all of the heart’s electrical activity to pause at once. That brief reset gives the heart’s natural pacemaker cells a chance to take over and restore an organized rhythm. The longer fibrillation continues, the more oxygen-starved and electrically unstable the heart becomes, which is why each passing minute makes a successful shock less likely.
Energy Levels and Shock Delivery
Modern defibrillators use a biphasic waveform, meaning the electrical current reverses direction partway through the shock. This design works at lower energy levels than older monophasic devices. For a biphasic defibrillator, the initial shock is typically set between 120 and 200 joules, depending on the manufacturer. If the first shock doesn’t restore a normal rhythm, each subsequent shock should be at the same or a higher energy level, stepping up to the maximum the device allows.
Older monophasic defibrillators deliver all energy in one direction and require 360 joules. Most hospitals and emergency services now use biphasic devices, and automated external defibrillators (AEDs) found in public spaces are also biphasic.
The Role of CPR Between Shocks
Defibrillation alone isn’t enough. High-quality chest compressions keep some blood flowing to the brain and heart while rescuers prepare for or deliver shocks. The American Heart Association specifies compressions at a rate of 100 to 120 per minute, pressing at least 2 inches deep on an adult’s chest, and allowing the chest to fully recoil between compressions.
If a shock doesn’t convert the rhythm, CPR resumes immediately for another two-minute cycle before reassessing. This alternating pattern of compressions and shocks continues throughout resuscitation. Minimizing pauses in compressions, even during shock delivery, is one of the strongest predictors of whether someone survives.
Medications for Shock-Resistant Cases
When ventricular fibrillation persists after multiple shocks, medications are added to the treatment sequence. The 2025 American Heart Association guidelines recommend two main categories of drugs.
Epinephrine is given intravenously every 3 to 5 minutes during cardiac arrest. It constricts blood vessels throughout the body, directing more of the blood moved by chest compressions toward the heart and brain. This doesn’t fix the rhythm directly, but it improves the conditions under which defibrillation can succeed.
If the heart remains in fibrillation after repeated shocks and epinephrine, an antiarrhythmic drug is added. Amiodarone is the first choice, given as an initial 300 mg dose followed by a second 150 mg dose if needed. Lidocaine is an alternative for settings where amiodarone isn’t available. These drugs stabilize the heart’s electrical activity, making the next shock more likely to work.
Options for Refractory Ventricular Fibrillation
A small percentage of patients remain in ventricular fibrillation despite standard shocks, CPR, and medications. This is called refractory VF. One technique gaining attention is double sequential external defibrillation (DSED), which involves placing two defibrillators on the patient and delivering shocks in rapid sequence from different angles.
A trial published in the New England Journal of Medicine found that patients with refractory VF who received DSED or a related technique called vector-change defibrillation (repositioning the pads to alter the shock’s path through the heart) survived to hospital discharge more often than those who received repeated standard shocks. The 2025 AHA guidelines now include guidance on double sequential defibrillation, though the logistics of having two defibrillators on scene remain a practical challenge for many emergency services.
What Happens After the Heart Restarts
Restoring a heartbeat is only the first step. The period after resuscitation carries its own serious risks, particularly brain injury from the minutes spent without adequate blood flow. Post-resuscitation care follows a structured bundle of interventions designed to protect the brain and stabilize the body.
Temperature management is central to this phase. Patients who remain unconscious after their heart restarts are cooled to a target range of 33°C to 36°C (about 91°F to 97°F) for at least 24 hours. This reduces the brain’s oxygen demand and limits the damage caused by inflammation and harmful molecules that surge when blood flow returns. Fever is actively prevented in all cardiac arrest survivors with impaired consciousness, since even mildly elevated temperatures worsen brain outcomes.
The care team also works to identify and treat whatever caused the cardiac arrest in the first place. Blood sugar is kept in a controlled range, seizures are managed aggressively, oxygen levels are monitored to avoid both too little and too much oxygen, and the heart’s pumping function is assessed by echocardiography within the first 24 to 48 hours. If a blocked coronary artery triggered the event, catheterization to reopen that vessel is a priority.
Preventing a Second Episode
Survivors of ventricular fibrillation face a meaningful risk of it happening again. The standard recommendation for secondary prevention is an implantable cardioverter-defibrillator (ICD), a small device placed under the skin of the chest that continuously monitors the heart’s rhythm. If it detects ventricular fibrillation or dangerously fast ventricular rhythms, it delivers an internal shock within seconds.
ICD implantation is recommended for VF survivors when the event wasn’t caused by a fully reversible trigger (like a drug reaction or a severe electrolyte imbalance that won’t recur). Guidelines specify that candidates should be on appropriate long-term medications and have a reasonable expectation of meaningful survival for more than one year. For patients with weakened heart muscle, particularly those with an ejection fraction of 40% or below, the recommendation is especially strong regardless of whether the underlying cause is a previous heart attack or another form of heart disease.
The ICD doesn’t prevent arrhythmias from starting, but it terminates them within seconds, essentially giving the patient a built-in defibrillator that works before emergency services could ever arrive.